Frequently Asked Questions
The market is segmented based on , By Type (Primary Hypertension, Secondary Hypertension, Others), Measurement Categories (Normal Blood Pressure, Elevated Blood Pressure, Stage 1 Hypertension, Stage 2 Hypertension, Others), Treatment (Medication, Additional Therapy, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Hypertension Market size was valued at USD 31.76 USD Billion in 2022.
The Global Hypertension Market is projected to grow at a CAGR of 4% during the forecast period of 2023 to 2030.
The major players operating in the market include F. Hoffmann La Roche Ltd, Fresenius Kabi AG, Bayer AG, Sun Pharmaceutical Industries Ltd, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd, Zydus Group, Pfizer , Lupin, GSK Plc, Glenmark Pharmaceuticals , Wockhardt.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
